Immunization in Canada: Update for 2015.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93

Ten great public health achievements--United States, 1900-1999. MMWR Morb Mortal Wkly Rep (1999) 8.67

Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med (2008) 7.79

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015) 4.23

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep (2013) 3.08

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06

Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet (2014) 2.71

The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine (2013) 2.25

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine. N Engl J Med (2015) 2.08

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis (2015) 1.97

An analytical framework for immunization programs in Canada. Vaccine (2005) 1.84

Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis (2014) 1.82

Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med (2013) 1.79

Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis (2008) 1.10

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine (2013) 1.08

Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine (2013) 1.04

Recent advances in Ebolavirus vaccine development. Hum Vaccin (2010) 1.01

Improving immunogenicity and effectiveness of influenza vaccine in older adults. Expert Rev Vaccines (2011) 0.99

Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine (2014) 0.98

Varicella vaccine update: need for a booster? CMAJ (2003) 0.97

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis (2015) 0.95

Cost effectiveness of infant vaccination for rotavirus in Canada. Can J Infect Dis Med Microbiol (2012) 0.89

Approved but non-funded vaccines: accessing individual protection. Vaccine (2013) 0.86

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization. Hum Vaccin Immunother (2015) 0.84

Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults. Hum Vaccin Immunother (2015) 0.82

Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity. Clin Vaccine Immunol (2013) 0.82

Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011. Clin Infect Dis (2014) 0.81

Immunization in Canada: a 6-year update. J Can Chiropr Assoc (2010) 0.80